WHO ICTRP trial
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Nanosomal…
CTRI/2014/11/005204 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2014/11/005204 |
|---|---|
| Public title | A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Nanosomal Docetaxel Lipid Suspension for Injection in Locally Advanced or Metastatic Breast Cancer Patients. |
| Scientific title | An Open Label, Parallel, Randomized Study to Evaluate the pharmacokinetics, Safety and Efficacy at three doses of Nanosomal Docetaxel Lipid Suspension for Injection in Locally Advanced or Metastatic Breast Cancer Patients after failure of prior chemotherapy. - NA |
| Primary sponsor | Intas Pharmaceuticals Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: C509- Malignant neoplasm of breast of unspecified site |
| Interventions | Intervention1: NDLS_Intas: Dose: 60, 75 and 100 mg/m2, Mode of Administration: IV, Duration of treatment and frequency:6 cycles (21 days per cycle) Control Intervention1: Not Applicable: Not Applicable |
| Registration date | Nov 14, 2014 |
| Target size | 90 |
| Secondary IDs | 740-14; Version 01; 17 Sep 14 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: